Christopher Haqq

Christopher Haqq has an estimated net worth of $11.7 Million. This is based on reported shares across multiple companies, which include Atara Biotherapeutics, Inc., Surrozen, Inc./DE, and Elicio Therapeutics, Inc..

2015 was Christopher Haqq's most active year for acquiring shares with 6 total transactions. Christopher Haqq's most active month to acquire stocks was the month of January. 2015 was Christopher Haqq's most active year for disposing of shares, totalling 19 transactions. Christopher Haqq's most active month to dispose stocks was the month of January. 2018 saw Christopher Haqq paying a total of $275,000.00 for 78,053 shares, this is the most they've acquired in one year. In 2018 Christopher Haqq cashed out on 125,556 shares for a total of $4,162,774.98, their largest year based on trade value.